Importer of Controlled Substances Application: Vici Health Sciences, LLC, 8303 [2025-01767]

Download as PDF 8303 Federal Register / Vol. 90, No. 17 / Tuesday, January 28, 2025 / Notices No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and UHD Alliance intends to file additional written notifications disclosing all changes in membership. On June 17, 2015, UHD Alliance filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on July 17, 2015 (80 FR 42537). The last notification was filed with the Department on October 8, 2024. A notice was published in the Federal Register pursuant to section 6(b) of the Act on December 20, 2024 (89 FR 104209). Suzanne Morris, Deputy Director Civil Enforcement Operations, Antitrust Division. antitrust plaintiffs to actual damages under specified circumstances. Specifically, Project Navigator, Ltd. (A Verdantas Company), Tustin, CA, has become a party to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and PERF intends to file additional written notifications disclosing all changes in membership. On February 10, 1986, PERF filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on March 14, 1986 (51 FR 8903). The last notification was filed with the Department on July 15, 2024. A notice was published in the Federal Register pursuant to section 6(h) of the Act on October 11, 2024 (89 FR 82632). Suzanne Morris, Deputy Director Civil Enforcement Operations, Antitrust Division. [FR Doc. 2025–01818 Filed 1–27–25; 8:45 am] BILLING CODE P [FR Doc. 2025–01824 Filed 1–27–25; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Antitrust Division DEPARTMENT OF JUSTICE Notice Pursuant to the National Cooperative Research and Production Act of 1993—Petroleum Environmental Research Forum Drug Enforcement Administration Notice is hereby given that, on December 17, 2024, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1933, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Petroleum Environmental Research Forum (‘‘PERF’’) filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of [Docket No. DEA–1449] Importer of Controlled Substances Application: Vici Health Sciences, LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Vici Health Sciences, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and SUMMARY: applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before February 27, 2025. Such persons may also file a written request for a hearing on the application on or before February 27, 2025. The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: In accordance with 21 CFR 1301.34(a), this is notice that on October 4, 2024, Vici Health Sciences, LLC, 6655 Amberton Drive, Suite O, Elkridge, Maryland 21075–6202 applied to be registered as an importer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: Drug code Controlled substance ddrumheller on DSK120RN23PROD with NOTICES1 Fentanyl-related compounds as defined in 21 CFR 1308.11(h) .................................................................................................. The company plans to import the listed controlled substance as part of a manufacturing process supporting research and clinical trial efforts. No other activity for this drug code is authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug VerDate Sep<11>2014 17:49 Jan 27, 2025 Jkt 265001 Administration-approved or nonapproved finished dosage forms for commercial sale. Matthew Strait, Deputy Assistant Administrator. PO 00000 DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances Application: Aveva Drug Delivery Systems, Inc. Drug Enforcement Administration, Justice. AGENCY: Frm 00047 Fmt 4703 Sfmt 4703 I [Docket No. DEA–1454] [FR Doc. 2025–01767 Filed 1–27–25; 8:45 am] BILLING CODE 4410–09–P 9850 Schedule E:\FR\FM\28JAN1.SGM 28JAN1

Agencies

[Federal Register Volume 90, Number 17 (Tuesday, January 28, 2025)]
[Notices]
[Page 8303]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-01767]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1449]


Importer of Controlled Substances Application: Vici Health 
Sciences, LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Vici Health Sciences, LLC has applied to be registered as an 
importer of basic class(es) of controlled substance(s). Refer to 
Supplementary Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants, therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
February 27, 2025. Such persons may also file a written request for a 
hearing on the application on or before February 27, 2025.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment. All 
requests for a hearing must be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152. All requests for a hearing should also be 
sent to: Drug Enforcement Administration, Attn: Administrator, 8701 
Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on October 4, 2024, Vici Health Sciences, LLC, 6655 
Amberton Drive, Suite O, Elkridge, Maryland 21075-6202 applied to be 
registered as an importer of the following basic class(es) of 
controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Fentanyl-related compounds as defined       9850  I
 in 21 CFR 1308.11(h).
------------------------------------------------------------------------

    The company plans to import the listed controlled substance as part 
of a manufacturing process supporting research and clinical trial 
efforts. No other activity for this drug code is authorized for this 
registration.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of Food and Drug Administration-approved or non-approved finished 
dosage forms for commercial sale.

Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025-01767 Filed 1-27-25; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.